Identification and Characterization of Nonmuscle Myosin II-C, a New Member of the Myosin II Family*

  1. Robert S. Adelstein
  1. Laboratory of Molecular Cardiology, NHLBI, the Genetics and Genomics Branch, NIAMS, and the **Developmental Metabolic Neurology Branch, NINDS, National Institutes of Health, Bethesda, Maryland 20892 and the §Department of Pathology, Shaare Zedek Medical Center, Jerusalem 91031, Israel
  1. To whom correspondence should be addressed: Dept. of Pathology, Shaare Zedek Medical Center, Jerusalem 91031, Israel. E-mail: golomb{at}szmc.org.il.

Abstract

A previously unrecognized nonmuscle myosin II heavy chain (NMHC II), which constitutes a distinct branch of the nonmuscle/smooth muscle myosin II family, has recently been revealed in genome data bases. We characterized the biochemical properties and expression patterns of this myosin. Using nucleotide probes and affinity-purified antibodies, we found that the distribution of NMHC II-C mRNA and protein (MYH14) is widespread in human and mouse organs but is quantitatively and qualitatively distinct from NMHC II-A and II-B. In contrast to NMHC II-A and II-B, the mRNA level in human fetal tissues is substantially lower than in adult tissues. Immunofluorescence microscopy showed distinct patterns of expression for all three NMHC isoforms. NMHC II-C contains an alternatively spliced exon of 24 nucleotides in loop I at a location analogous to where a spliced exon appears in NMHC II-B and in the smooth muscle myosin heavy chain. However, unlike neuron-specific expression of the NMHC II-B insert, the NMHC II-C inserted isoform has widespread tissue distribution. Baculovirus expression of noninserted and inserted NMHC II-C heavy meromyosin (HMM II-C/HMM II-C1) resulted in significant quantities of expressed protein (mg of protein) for HMM II-C1 but not for HMM II-C. Functional characterization of HMM II-C1 by actin-activated MgATPase activity demonstrated a Vmax of 0.55 + 0.18 s–1, which was half-maximally activated at an actin concentration of 16.5 + 7.2 μm. HMM II-C1 translocated actin filaments at a rate of 0.05 + 0.011 μm/s in the absence of tropomyosin and at 0.072 + 0.019 μm/s in the presence of tropomyosin in an in vitro motility assay.

  • Received September 8, 2003.
  • Revision received October 20, 2003.
Table of Contents

Submit your work to JBC.

You'll be in good company.